Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease

Brenna C. Beckelman, Stephen Day, Xueyan Zhou, Maggie Donohue, Gunnar K. Gouras, Eric Klann, C. Dirk Keene, Tao Ma

Research output: Contribution to journalArticle

Abstract

Synaptic dysfunction may represent an early and crucial pathophysiology in Alzheimer's disease (AD). Recent studies implicate a connection between synaptic plasticity deficits and compromised capacity of de novo protein synthesis in AD. The mRNA translational factor eukaryotic elongation factor 1A (eEF1A) is critically involved in several forms of long-lasting synaptic plasticity. By examining postmortem human brain samples, a transgenic mouse model, and application of synthetic human Aβ42 on mouse hippocampal slices, we demonstrated that eEF1A protein levels were significantly decreased in AD, particularly in the hippocampus. In contrast, brain levels of eukaryotic elongation factor 2 were unaltered in AD. Further, upregulation of eEF1A expression by the adenylyl cyclase activator forskolin, which induces long-lasting synaptic plasticity, was blunted in hippocampal slices derived from Tg2576 AD model mice. Finally, Aβ-induced hippocampal long-term potentiation defects were alleviated by upregulation of eEF1A signaling via brain-specific knockdown of the gene encoding tuberous sclerosis 2. In summary, our findings suggest a strong correlation between the dysregulation of eEF1A synthesis and AD-associated synaptic failure. These findings provide insights into the understanding of molecular mechanisms underlying AD etiology and may aid in identification of novel biomarkers and therapeutic targets.

Original languageEnglish (US)
Pages (from-to)669-678
Number of pages10
JournalJournal of Alzheimer's Disease
Volume54
Issue number2
DOIs
StatePublished - Sep 6 2016

Fingerprint

Peptide Elongation Factors
Neuronal Plasticity
Alzheimer Disease
Brain
Up-Regulation
Peptide Elongation Factor 2
Gene Knockdown Techniques
Long-Term Potentiation
Colforsin
Adenylyl Cyclases
Transgenic Mice
Hippocampus
Proteins
Biomarkers
Messenger RNA

Keywords

  • Alzheimer's disease
  • elongation factor
  • long-term potentiation
  • mTOR
  • protein synthesis
  • synaptic plasticity

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease. / Beckelman, Brenna C.; Day, Stephen; Zhou, Xueyan; Donohue, Maggie; Gouras, Gunnar K.; Klann, Eric; Keene, C. Dirk; Ma, Tao.

In: Journal of Alzheimer's Disease, Vol. 54, No. 2, 06.09.2016, p. 669-678.

Research output: Contribution to journalArticle

Beckelman, Brenna C. ; Day, Stephen ; Zhou, Xueyan ; Donohue, Maggie ; Gouras, Gunnar K. ; Klann, Eric ; Keene, C. Dirk ; Ma, Tao. / Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease. In: Journal of Alzheimer's Disease. 2016 ; Vol. 54, No. 2. pp. 669-678.
@article{ad0540183c7244e2a3d87ed91b9968bf,
title = "Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease",
abstract = "Synaptic dysfunction may represent an early and crucial pathophysiology in Alzheimer's disease (AD). Recent studies implicate a connection between synaptic plasticity deficits and compromised capacity of de novo protein synthesis in AD. The mRNA translational factor eukaryotic elongation factor 1A (eEF1A) is critically involved in several forms of long-lasting synaptic plasticity. By examining postmortem human brain samples, a transgenic mouse model, and application of synthetic human Aβ42 on mouse hippocampal slices, we demonstrated that eEF1A protein levels were significantly decreased in AD, particularly in the hippocampus. In contrast, brain levels of eukaryotic elongation factor 2 were unaltered in AD. Further, upregulation of eEF1A expression by the adenylyl cyclase activator forskolin, which induces long-lasting synaptic plasticity, was blunted in hippocampal slices derived from Tg2576 AD model mice. Finally, Aβ-induced hippocampal long-term potentiation defects were alleviated by upregulation of eEF1A signaling via brain-specific knockdown of the gene encoding tuberous sclerosis 2. In summary, our findings suggest a strong correlation between the dysregulation of eEF1A synthesis and AD-associated synaptic failure. These findings provide insights into the understanding of molecular mechanisms underlying AD etiology and may aid in identification of novel biomarkers and therapeutic targets.",
keywords = "Alzheimer's disease, elongation factor, long-term potentiation, mTOR, protein synthesis, synaptic plasticity",
author = "Beckelman, {Brenna C.} and Stephen Day and Xueyan Zhou and Maggie Donohue and Gouras, {Gunnar K.} and Eric Klann and Keene, {C. Dirk} and Tao Ma",
year = "2016",
month = "9",
day = "6",
doi = "10.3233/JAD-160036",
language = "English (US)",
volume = "54",
pages = "669--678",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease

AU - Beckelman, Brenna C.

AU - Day, Stephen

AU - Zhou, Xueyan

AU - Donohue, Maggie

AU - Gouras, Gunnar K.

AU - Klann, Eric

AU - Keene, C. Dirk

AU - Ma, Tao

PY - 2016/9/6

Y1 - 2016/9/6

N2 - Synaptic dysfunction may represent an early and crucial pathophysiology in Alzheimer's disease (AD). Recent studies implicate a connection between synaptic plasticity deficits and compromised capacity of de novo protein synthesis in AD. The mRNA translational factor eukaryotic elongation factor 1A (eEF1A) is critically involved in several forms of long-lasting synaptic plasticity. By examining postmortem human brain samples, a transgenic mouse model, and application of synthetic human Aβ42 on mouse hippocampal slices, we demonstrated that eEF1A protein levels were significantly decreased in AD, particularly in the hippocampus. In contrast, brain levels of eukaryotic elongation factor 2 were unaltered in AD. Further, upregulation of eEF1A expression by the adenylyl cyclase activator forskolin, which induces long-lasting synaptic plasticity, was blunted in hippocampal slices derived from Tg2576 AD model mice. Finally, Aβ-induced hippocampal long-term potentiation defects were alleviated by upregulation of eEF1A signaling via brain-specific knockdown of the gene encoding tuberous sclerosis 2. In summary, our findings suggest a strong correlation between the dysregulation of eEF1A synthesis and AD-associated synaptic failure. These findings provide insights into the understanding of molecular mechanisms underlying AD etiology and may aid in identification of novel biomarkers and therapeutic targets.

AB - Synaptic dysfunction may represent an early and crucial pathophysiology in Alzheimer's disease (AD). Recent studies implicate a connection between synaptic plasticity deficits and compromised capacity of de novo protein synthesis in AD. The mRNA translational factor eukaryotic elongation factor 1A (eEF1A) is critically involved in several forms of long-lasting synaptic plasticity. By examining postmortem human brain samples, a transgenic mouse model, and application of synthetic human Aβ42 on mouse hippocampal slices, we demonstrated that eEF1A protein levels were significantly decreased in AD, particularly in the hippocampus. In contrast, brain levels of eukaryotic elongation factor 2 were unaltered in AD. Further, upregulation of eEF1A expression by the adenylyl cyclase activator forskolin, which induces long-lasting synaptic plasticity, was blunted in hippocampal slices derived from Tg2576 AD model mice. Finally, Aβ-induced hippocampal long-term potentiation defects were alleviated by upregulation of eEF1A signaling via brain-specific knockdown of the gene encoding tuberous sclerosis 2. In summary, our findings suggest a strong correlation between the dysregulation of eEF1A synthesis and AD-associated synaptic failure. These findings provide insights into the understanding of molecular mechanisms underlying AD etiology and may aid in identification of novel biomarkers and therapeutic targets.

KW - Alzheimer's disease

KW - elongation factor

KW - long-term potentiation

KW - mTOR

KW - protein synthesis

KW - synaptic plasticity

UR - http://www.scopus.com/inward/record.url?scp=84986557839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986557839&partnerID=8YFLogxK

U2 - 10.3233/JAD-160036

DO - 10.3233/JAD-160036

M3 - Article

VL - 54

SP - 669

EP - 678

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -